RxDoctor Payments Data

Bretteney Hyppolite

Psychiatric/Mental Health · Worcester, MANPI 1285373506

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.2% of the total across 213 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $3,484 and has fallen 80.5% since, to $679 in 2025. Among psychiatric/mental health clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,776in general payments, 2019–2025

Across 213 payments — averaging $27.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$1K
  • Otsuka America Pharmaceutical, Inc.$958
  • AbbVie$804
  • Alkermes, Inc.$631
  • Johnson & Johnson$624
  • Axsome Therapeutics, Inc.$335
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$5,55496%
  • Education$2224%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,776 in reported general payments places this provider in the 95th percentile of 1,284 psychiatric/mental health providers in Massachusetts.

See all psychiatric/mental health providers in Massachusetts

Medicare billing

Part B allowed, 2024
$34,778
Medicare patients
171
Services billed
591

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lurasidone Hcl23$8,437
Aripiprazole36$2,387
Duloxetine Hcl49$1,671
Divalproex Sodium ErDivalproex Sodium11$1,101
Clonazepam117$864
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine56$848
Gabapentin30$818
Citalopram HbrCitalopram Hydrobromide15$776
Hydroxyzine Hcl20$729
Quetiapine Fumarate36$681
Lamotrigine57$676
Venlafaxine Hcl ErVenlafaxine Hcl26$601
Buspirone Hcl27$566
Lorazepam58$564
Trazodone Hcl53$539

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Worcester

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →